Bandung, November 29, 2025 –The Konsorsium Bioteknologi Indonesia (KBI) actively participated in SYNBIOTECHFEST 2025, held on November 29 at the Multipurpose Hall CRCS ITB, Bandung. Organized by Synbio.id, this event served as a critical hub for the “triple helix” of academia, industry, and government to accelerate Indonesia’s bio-economy through synthetic biology.

To demonstrate its commitment to the national biotechnology landscape, KBI established a presence at the event through an exhibition booth. The booth was represented by Sara Wijayanti, the KBI Executive Secretary, who engaged directly with researchers and industry stakeholders to strengthen the consortium’s professional network.

The festival’s agenda featured prominent figures from the KBI network who delivered deep dives into the technical and human aspects of biotechnology:

  • Unlocking Natural Assets: Prof. Dr. Fenny M. Dwivany from the School of Life Sciences and Technology, Bandung Institute of Technology (SITH ITB), a KBI institutional member, presented on “Application of Genomics and Synthetic Biology to Indonesia’s Biodiversity.” In her session, Prof. Fenny emphasized that Indonesia’s mega-biodiversity should no longer be viewed solely as a raw resource, but as a genetic library. She highlighted how genomic data, combined with synthetic biology tools, can unlock sustainable solutions for agriculture and health, effectively transitioning Indonesia toward a knowledge-based bio-economy.

  • Redefining the Scientist: Revata Utama, Founder and CEO of Nusantics (a KBI industry member), delivered an inspiring talk titled “The Epitome of Future Scientific Heroes.” Moving beyond technical data, Revata addressed the changing role of scientists in modern society. He argued that the next generation of researchers must view themselves as problem-solvers and innovators—”heroes” capable of tackling planetary crises through bio-entrepreneurship and resilience, rather than remaining confined to traditional academic silos.

Additionally, dr. Vincentius Simeon Weo Budhyanto, Chairman and Director of the Satriabudi Dharma Setia Foundation (YSDS), a strategic partner of KBI, addressed the intersection of philanthropy and health innovation, reinforcing the need for sustainable funding models in research.

KBI extends its sincere appreciation to Synbio.id for the invitation to collaborate and for successfully organizing a platform that amplifies the potential of synthetic biology in Indonesia. KBI is committed to continuing this partnership to drive future innovations.

GALLERY